癌症复发恐惧量表汉化及信效度初测  

Chinese version of fear of cancer recurrence questionnaire for cancer patients: a preliminary study

作　　者：张永福 谭晓敏 孙恒文[3] 孙志辉 张晶莹 刘婷[5] 王宏梅[6] 梁卫江[7] 杨源 Zhang Yongfu;Tan Xiaomin;Sun Hengwen;Sun Zhihui;Zhang Jingying;Liu Ting;Wang Hongmei;Liang Weijiang;Yang Yuan(Anesthesiology Department of Guangzhou Women and Children's Medical Center,Guangzhou 510623,China;Department of Education,Southern Medical University Nanfang Hospital,Guangzhou 510515,China;Department of Radiotherapy,Cancer Center,Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences),Guangzhou 510080,China;Dept of International Medical Services,The people’s Hospital of SND,Suzhou 215000,China;Dept of Psychiatry,Southern Medical University Nanfang Hospital,Guangzhou 510515,China;Dept of Radiotherapy,Southern Medical University Nanfang Hospital,Guangzhou 510515,China;Dept of Oncology,Southern Medical University Nanfang Hospital,Guangzhou 510515,China)

机构地区：[1]广州市妇女儿童医疗中心麻醉科,广东广州510623 [2]南方医科大学南方医院教务处,广东广州510515 [3]广东省人民医院(广东省医学科学院)肿瘤中心放疗科,广东广州510080 [4]苏州高新区人民医院国际医学部,江苏苏州215000 [5]南方医科大学南方医院精神心理科,广东广州510515 [6]南方医科大学南方医院放疗科,广东广州510515 [7]南方医科大学南方医院肿瘤科,广东广州510515

出　　处：《中华卫生应急电子杂志》2019年第3期157-163,共7页Chinese Journal of Hygiene Rescue(Electronic Edition)

基　　金：南方医科大学南方医院院长基金(2017L001);广州市科技计划基金(201804010132)

摘　　要：目的汉化英文版癌症复发恐惧量表(FCRQ)及初步分析其在评估癌症患者复发恐惧心理中的信效度。方法经过量表翻译、回译、专家小组评议调适后形成癌症复发恐惧量表初步汉化版。采取回顾性分析2018年1月至2018年12月在南方医科大学南方医院、广东省人民医院及广州市妇女儿童医疗中心肿瘤中心收治的571例癌症病例资料,其中男性52例,女性519例;年龄21~88岁,平均(47.50±11.43)岁。使用癌症复发恐惧量表(FCRQ)、恐惧疾病进展简化量表(FoP-Q-SF)、抑郁症筛查量表(PHQ-9)与焦虑症筛查量表(GAD-7)进行评估,同时收集患者社会人口学资料。一个月后采用随机数表法简单随机抽取50%(285名)患者进行复测,计算量表复测信度。结果量表克朗巴哈系数(Cronbach’s alpha)为0.86,Spearman Brown分半信度为0.89,重测信度为0.90。探索性因子分析显示量表为单因子结构,可解释总变异65.91%。量表各条目与总分的相关系数为0.575~0.874。除条目6外(因子载荷0.577),其余条目在主成分载荷为0.787~0.894。汉化版FCRQ量表与FoP-Q-SF、PHQ9与GAD7均呈正相关(相关系数0.524~0.758,P<0.05)。结论汉化版癌症复发恐惧量表具有良好的信效度,可以作为国内开展相关领域研究的临床评估工具。Objective To translate the English version of the Fear of Cancer Recurrence Questionnaire(FCRQ)into Chinese and to test its validity and reliability among Chinese cancer patients. Methods After we achieved a draft Chinese version, we recruited 571 cancer patients(52 males and 519 females, mean age: 47.50±11.43 years, range from 21 to 88 years) from Southern Medical University Nanfang Hospital, Guangdong Provincial People’s Hospital and Guangzhou Women and Children’s Medical Center and asked them to complete the FCRQ, the Fear of Progression Questionnaire – Short Form(FoP-Q-SF), the Patient Health Questionnaire(PHQ-9) and the General Anxiety Disorder Questionnaire(GAD-7). Cronbach’s alpha was calculated and Explorary Factorial Analysis(EFA)was conducted. Fifty percent of the participants were randomly selected and re-contacted after one month to explore the test-retest reliability. Results The Cronbach’s alpha of the Chinese FCRQ scale was 0.86, Spearman Brown coefficient was 0.89, and the test-retest coefficient was 0.90. EFA revealed that the scale was a single factor instrument, and it explained up to 65.91% of the total variance. The r value between scale item and total score ranged from 0.575 to 0.876, and their loadings showed satisfactory outcomes(ranged from 0.787 to 0.894)except for item 6(loading=0.577). The FCRQ showed significant correlation with FoP-Q-SF, PHQ9 and GAD7 scales(r values ranged from 0.524-0.758). Conclusion The Chinese version FCRQ is reliable and could be utilized in the field of cancer research.

关 键 词：肿瘤 量表 信度 效度 复发恐惧 

分 类 号：R73-31[医药卫生—肿瘤]